Cargando…

SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma

Liver Hepatocellular Carcinoma (LIHC) is the fifth widely occurred carcinoma, which is thought to be the second primary contributor of carcinoma-associated death. There are almost 788,000 death tolls worldwide. Solute carrier family 41 member 3 (SLC41A3) is a member of solute carrier family 41, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Qimeng, Xu, Yayun, Wang, Jianfa, Jing, Hui, Rao, Longhua, Tang, Weiguo, Zhang, Ziping, Wu, Xubo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608493/ https://www.ncbi.nlm.nih.gov/pubmed/34819993 http://dx.doi.org/10.1155/2021/8556888

Ejemplares similares

Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin
por: Xu, Yayun, et al.
Publicado: (2023)

RORγt inhibitor SR1001 alleviates acute pancreatitis by suppressing pancreatic IL‐17‐producing Th17 and γδ‐T cells in mice with ceruletide‐induced pancreatitis
por: Wang, Jianfa, et al.
Publicado: (2021)

Role of Asxl2 in non-alcoholic steatohepatitis-related hepatocellular carcinoma developed from diabetes
por: Hu, Zhiqiu, et al.
Publicado: (2021)

Disordered Gut Microbiota Correlates With Altered Fecal Bile Acid Metabolism and Post-cholecystectomy Diarrhea
por: Xu, Yayun, et al.
Publicado: (2022)

Effect of aging on acute pancreatitis through gut microbiota
por: Jing, Hui, et al.
Publicado: (2022)

High Expression of SLC41A3 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Li, Qian, et al.
Publicado: (2021)

Severe acute pancreatitis concurrent with lethal rupture of cerebral aneurysm: A case report and review of the literature
por: Xu, Yayun, et al.
Publicado: (2020)

Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors
por: Gao, Qimeng, et al.
Publicado: (2021)

SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase
por: Xu, Feng-li, et al.
Publicado: (2023)

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression
por: Ma, Xiaowu, et al.
Publicado: (2022)

Comprehensive analysis of SLC43A2 on the tumor immune microenvironment and prognosis of liver hepatocellular carcinoma
por: Liao, Yan, et al.
Publicado: (2022)

MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma
por: Hayes, C. Nelson, et al.
Publicado: (2016)

SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma
por: Chen, Qianping, et al.
Publicado: (2022)

Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma
por: Wang, Dongyao, et al.
Publicado: (2022)

Biomarkers for Hepatocellular Carcinoma
por: Behne, Tara, et al.
Publicado: (2012)

Biomarkers for Hepatocellular Carcinoma
por: Lou, Jiatao, et al.
Publicado: (2017)

Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs for hepatocellular carcinoma treatment
por: Ma, Haili, et al.
Publicado: (2017)

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

SLC41A1 is essential for magnesium homeostasis in vivo
por: Arjona, Francisco J., et al.
Publicado: (2018)

METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
por: Bi, Fangfang, et al.
Publicado: (2023)

Exploration of Prognostic Biomarkers among Replication Factor C Family in the Hepatocellular Carcinoma
por: Deng, Jianxiong, et al.
Publicado: (2021)

Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma
por: Xu, Wei, et al.
Publicado: (2018)

Systemic characterization of the SLC family genes reveals SLC26A6 as a novel oncogene in hepatocellular carcinoma
por: Cao, Jianzhong, et al.
Publicado: (2021)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma
por: Chen, Long, et al.
Publicado: (2013)

Expression of SLC17A9 in hepatocellular carcinoma and its clinical significance
por: Wu, Jingdong, et al.
Publicado: (2020)

Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma
por: Yin, Xieling, et al.
Publicado: (2022)

PS41. Hypermethylation of SLC6A4 promoter in psychiatric disorders suppresses its expression.
por: Ikegame, Tempei, et al.
Publicado: (2016)

ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma
por: Deng, Tingting, et al.
Publicado: (2022)

Correlation Between Prognostic Biomarker SLC1A5 and Immune Infiltrates in Various Types of Cancers Including Hepatocellular Carcinoma
por: Zhao, Junsheng, et al.
Publicado: (2021)

SLC7A2 deficiency promotes hepatocellular carcinoma progression by enhancing recruitment of myeloid-derived suppressors cells
por: Xia, Suhong, et al.
Publicado: (2021)

Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
por: Citores, Maria J, et al.
Publicado: (2019)

Mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver
por: Tanaka, Haruka, et al.
Publicado: (2022)

Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion
por: Li, Yanhua, et al.
Publicado: (2016)

Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma
por: Kui, Xue-Yan, et al.
Publicado: (2022)

Radioresistant Nasopharyngeal Carcinoma Cells Exhibited Decreased Cisplatin Sensitivity by Inducing SLC1A6 Expression
por: Hao, Wenwen, et al.
Publicado: (2021)

Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT
por: Tang, Jianing, et al.
Publicado: (2023)

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma
por: Deng, Tingting, et al.
Publicado: (2022)

Liver Transplantation for Hepatocellular Carcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2008)

NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis
por: Huang, Jianfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_79jqtdjuelraurpcfrcdje7fe3